The yeast rna mutations (rna2 through rnalOIII) are a set of temperature-sensitive mutations that result in the accumulation of pre-mRNAs at the nonpermissive temperature. Most of the yeast RNA gene products are involved in and essential for mRNA splicing in vitro, suggesting that they code for components of the splicing machinery. We tested this proposal by using an in vitro-synthesized RNA11 protein to complement the temperature-sensitive defect of the rnall extract. During the in vitro complementation, the input RNA11 protein was associated with the 40S spliceosome and a 30S complex, suggesting that the RNA11 protein is indeed a component of the spliceosome. The formation of the RNAll-associated 30S complex did not require any exogenous RNA substrate, suggesting that this 30S particle is likely to be a preassembled complex involved in splicing. The RNAll-specific antibody inhibited the mRNA splicing in vitro, confirming the essential role of the RNA11 protein in mRNA splicing. Finally, using the anti-RNA1 antibody, we localized the RNA11 protein to the periphery of the yeast nucleus.
Through the development of in vitro splicing systems, a two-step biochemical pathway for the removal of introns from nuclear mRNA precursors (pre-mRNAs), referred to as mRNA splicing, has been delineated (for a review, see reference 42) . This splicing reaction is done on a 40S to 60S macromolecular complex, the spliceosome, on which the reaction intermediates are confined (4, 15, 16) . It is becoming apparent that the complexity of such a large particle may well be as great as that of the ribosomal subunits and that it could contain a number of proteins and several RNAs.
To date, five major classes of small nuclear RNAs (snRNAs; Ul, U2, U4 to U6) have been found to be involved in mammalian mRNA splicing (for a recent review, see reference 37) . Of these, four (Ul, U2, U4, and U5) possess a 5' trimethylguanosine (m3G) cap. All five snRNAs are tightly associated with one or more proteins and function in the form of small nuclear ribonucleoprotein particles (snRNPs) (48, 56) . The human autoimmune antiserum antiSm has been used to precipitate these snRNAs and to demonstrate that these snRNAs are required for mRNA splicing (28, 43) . The Sm antigens are a subset of snRNP proteins found in all five of the snRNPs which function in mRNA splicing (48) . In yeasts, snRNAs also possess the 5' m3G cap structure which renders them immunoprecipitable by the anti-m3G antibody (reviewed in reference 18). Furthermore, a subset of yeast snRNAs (e.g., snR7, snR14, and snR20) contain potential Sm antigen-binding sites in their single-stranded regions with a consensus sequence of A(U3-)G (2, 19, 44, 49, 50, 60) . Indeed, some of the human anti-Sm antisera can precipitate these snRNAs from the yeast extract (50, 60 ; S.-C. Cheng and J. Abelson, unpublished data).
Recent analyses of the spliceosomal components performed either by affinity purification of the spliceosome or by native gel fractionation of the in vitro splicing systems have revealed that several snRNPs (U2, U5, and U4 + U6 for mammalian cell systems; snR6, snR7, snR14, and snR20 for the yeast system) reside on the spliceosomes (8, 17, 26, 27, 46, 47) . In addition, the involvement of the heterogeneous nuclear RNP (hnRNP) complexes in mRNA splicing and spliceosome formation has been implicated by inhibition experiments with antibodies against the hnRNP core proteins (9, 53) . Spliceosome assembly follows a rather complicated pathway, with several spliceosome intermediates appearing in sequence (8, 17, 27, 46, 47) . The apparent complexity of the spliceosome and the mRNA splicing process demands a combined effort by both biochemical fractionation and genetic analysis to enumerate all the components involved in mRNA splicing and eventually to understand their functions.
Taking advantage of the well-characterized genetic properties and the readily available mutants of the yeast Saccharomnces cerei'isiae, we have begun to analyze the mRNAsplicing mechanism in detail. In particular, special attention has been focused on a set of temperature-sensitive mutations initially isolated by Hartwell (20) which form nine complementation groups denoted rna2 to rna10/11 (36) . Although originally thought to be defective in general RNA metabolism, these *-na mutants turn out to be functionally impaired in mRNA splicing at the nonpermissive temperature in a very specific manner (51; reviewed in reference 36) . By developing an in vitro complementation assay, Lustig et al. (36) have shown that many of the RNA genes are likely to code for products directly involved in and essential for mRNA splicing. In addition, most of the RNA gene products are required for the formation of spliceosomes in vitro, with an exception of the RNA2 gene product, which is a factor extrinsic to the spliceosome (33) . On the basis of these studies, Lin et al. (33) proposed a three-step mechanism for mRNA splicing and deduced multiple intrinsic and extrinsic factors which are involved in the formation of the spliceosome.
We proceeded to examine the role of one of the RNA gene products. the RNA11 protein, in mRNA splicing and its relationship to the spliceosome. In this study, we first demonstrated that the in vitro-synthesized RNA11 protein is capable of complementing the defects of heat-sensitive rnall extracts. We then provided evidence that the RNA11 protein is specifically associated with the 40S spliceosome and with a 30S complex. Finally, using an anti-RNA11 antibody, we showed that the RNA11 protein is essential for mRNA splicing in vitro and is localized predominantly in the periphery of the yeast nucleus.
MATERIALS AND METHODS
Yeast strains. The following yeast strains were used in this study: the wild-type strain EJ101; rna2 strain SS304; rna5 strain RL173; rnall strains SPJ11.4 and AJL145.9d. The genotypes of these strains have been described by Lin et al. (34) and Lustig et al. (36) .
Isolation of yeast splicing extracts. Extracts were prepared from cells grown to the mid-to late log phase at 23°C in YPD medium as described by Lustig et al. (36) .
Preparation of splicing substrates. The wild-type and C259 actin transcripts used in this study have been described previously (34, 58) . Low-specific-activity transcripts and antisense transcript were synthesized by the methods of Cheng and Abelson (8) .
Plasmid constructions and oligonucleotide-directed site-specific mutagenesis. Plasmid pAS1 containing the wild-type RNAJJ gene in a 4.6-kilobase (kb) Hindlll fragment cloned into pBR322 was kindly provided by R 23 ,700 x g (50,000 rpm) for 90 min at 2°C in a Beckman SW55 rotor. Fractions were collected, and radioactivities were determined by Cerenkov counting. Proteins and nucleic acids in each fraction were then precipitated by the addition of Triton X-100 to 0.1% and trichloroacetic acid to 5% and chilled to -20°C overnight. The trichloroacetic acid precipitates were collected by centrifugation, neutralized by 2 (30) . A silver staining technique (62) was used to visualize the proteins on the gel.
Preparation of the anti-RNAll antibody and immunoblot analysis. The overproduced RNAll protein was first separated from the bulk protein in the E. coli crude lysate by ammonium sulfate precipitation (55% cut), loaded on a heparin-agarose column, and eluted with a linear salt gradient (0.1 to 1.5 M NaCl). The peak fractions containing the RNAll protein (between 0.2 and 0.6 M NaCl) were pooled and concentrated by ammonium sulfate precipitation. Further purification of the RNA11 protein was achieved by SDS-14% PAGE (30) , and gel slices which contained the RNAll protein were then utilized to immunize New Zealand White male rabbits as described by Phizicky et al. (45) . The antibody thus obtained was used in immunoblot analysis to detect RNA11 protein in yeast extract or crude lysate prepared from the RNAll-overproducing E. coli strain. The procedures of electroblotting proteins onto nitrocellulose filters and visualization of the RNA11 protein with anti-RNA11 antibody, biotinylated secondary antibody, and horseradish peroxidase have been described previously (10, 57) .
Immunoprecipitation. Anti-m3G cap antibody and anti-Sm (no. 58) human autoimmune antibody were generous gifts from R. Luhrmann (Max-Planck-Institute, Berlin, Federal Republic of Germany) and S. Hoch (Agouron Institute, La Jolla, Calif.), respectively. The immunoprecipitation was performed essentially as described by Wolin and Steiz (61) . Antibodies (from anti-Sm, anti-m3G, and anti-RNA11 antisera or preimmune serum) were coupled to 2.5 mg of protein A-Sepharose (Pharmacia, Inc., Piscataway, N.J.) in 0.5 ml of NET-2 buffer (50 mM Tris [pH 7.4], 150 mM NaCl, 0.05% Nonidet P-40) at room temperature for 1 h. After NET-2 washes, the antibody-bound protein A-Sepharose was incubated with either in vitro translation reaction mixtures or in vitro complementation mixtures at 4°C for 1 h. The pellets were then washed extensively with NET-2 buffer and analyzed by protein gel electrophoresis followed by autoradiography. The 35S radioactivity was determined by incubating the gel slices of interest in 10 ml of Econofluor containing 3% Protosol (New England Nuclear Corp.) overnight at 37°C and subsequent liquid scintillation counting.
Antibody inhibition of mRNA splicing in vitro. Wild-type yeast extract (7 ,ul) Immunoelectron microscopy. A modified procedure (detailed in reference 10) of Byers and Goetsch (6) was used for immunoelectron microscopy. On-section immune staining of ultrathin sections was performed as described previously (10, 12) (52) . In Fig. 1 (Fig. 3, lane 4) . The truncated RNA11 protein is expected to be 109 amino acids long.
In vitro complementation. The activity of the in vitrosynthesized RNA11 protein in mRNA splicing was tested by an in vitro complementation assay. Normally, the heatinactivated rna2, rna5, and rnall mutant extracts could complement one another, regardless of whether the extracts were mixed before or after heat inactivation (36 inactivated rnall extract (now termed the nonfunctional complementation assay), the splicing activity of the extract was not restored. We reasoned that perhaps the RNA11 protein is an integral part of a temperature-sensitive complex which, upon heat inactivation, might be permanently inactivated. The addition of the free RNA11 protein after heat inactivation would thus fail to regenerate the function of the complex (see Discussion). We therefore tested an alternative procedure (summarized in Fig. 4A ) in which the heat inactivation of the rnal l,extract was performed in the presence of the RNAll translation mix, using conditions modified from that of Lustig et al. (36) . Subsequently, the 32P-labeled pre-mRNA substrate (wild-type actin transcript produced in vitro) was added, and conditions were adjusted for in vitro splicing. The splicing products were then analyzed by PAGE (Fig. 4B) . Under the conditions used in this assay, the full-length RNAll protein was able to restore the splicing activity (lane 4) to a level close to that of the active rnall extract (no heat inactivation; lane 1), while the mock translation mix (lane 2), the translated globin (lane 3), and the translated truncated RNA11 protein (data not shown) all failed to recover the splicing activity of the rnall extract lost owing to heat inactivation.
Association of RNA11 protein with functional spliceosome. It has been shown that a 40S complex (spliceosome) containing pre-mRNA and intermediates of the splicing reaction will form in active yeast extracts in the presence of a functional pre-mRNA and ATP (4, 58) . We wanted to investigate the fate of the RNA11 protein during spliceosome assembly. To this end, the distribution of the RNA11 protein in the course of spliceosome formation was analyzed by glycerol gradient sedimentation and SDS-PAGE (summarized in Fig. 4A) . Briefly, the in vitro complementation mix was fractionated on a 50 mM KCI gradient (11 to 23% glycerol), and the spliceosome assembly was monitored by Cerenkov counting of the 32P radioactivity across the gradient. Subsequently, the "S-labeled RNA11 protein as well as the 32P-labeled RNAs in each fraction were precipitated with trichloroacetic acid, resolved by SDS-PAGE, and subjected to autoradiography.
A small 40S peak at fraction 11 was detected together with a larger 30S peak at fraction 15 (Fig. 5A, top) . The result is consistent with the profile previously described by Lin et al. (33) . This 40S complex contains pre-mRNA and intermediates of the splicing reaction, and its formation is dependent on the presence of a functional pre-mRNA and ATP (data not shown). Thus, the 40S complex is a functional spliceosome. On the other hand, the 30S complex contains exclusively the uncleaved pre-mRNA, and its formation is ATP independent and depends only on the presence of a functional pre-mRNA (data not shown; see also reference 4). The positions of the 30S and 40S peaks in the 50 mM KCI gradient were different from the results previously obtained by using 100 mM KCl gradients (4, 33, 58) . It is known that the sedimentation of the splicing complexes undergoes a salt-dependent shift. At a higher salt concentration (e.g., 400 mM KCI), spliceosomes sediment more slowly than at a lower salt concentration (e.g., 50 mM KCI) in the gradient (4, 16, 17; S. Goelz and J. Abelson, unpublished data).
We then analyzed both the 35S-labeled RNA11 protein and 32P-labeled RNA molecules simultaneously on an SDSpolyacrylamide gel. Approximately 22 to 28% of the input RNA11 protein cosedimented with the 40S complex, and 57 to 68% cosedimented with the 30S complex (Fig. 5A, bot nor the globin was associated with any complex. Instead, both proteins remained on top of the gradients (Table 1) , in sharp contrast to the result with the full-length RNAll protein.
Interestingly, the migration pattern of the RNA splicing intermediates on the SDS-polyacrylamide gel resembled that seen on a urea-polyacrylamide gel (cf. the control lane in Fig. 6A and 4B) . On SDS gels, the 32P-labeled exon 1 (the fastest-migrating band in the 40S region) could be clearly distinguished from the 35S-labeled RNA11 protein based on the following criteria: (i) comigration of the fastest-migrating band in the 40S region with exon 1 generated from a standard splicing reaction (see control lane in Fig. 6A); (ii) the correlation of the calculated molecular weight of exon 1 with its distance of migration on the gel; (iii) the ability to detect the radiation emitted from 32P-labeled exon 1 by autoradiography through two layers of opaque X-ray films (35S radiation cannot penetrate the films). The location of exon 1 in the gradient is a clear marker for the spliceosome in these experiments.
It is possible that the RNA11 protein is bound nonspecifically to particles other than spliceosomes present in the 40S region. This possibility was ruled out by experiments with wild-type and rna2 extracts for in vitro complementation (Table 1) . Heat-inactivated rna2 extracts can support the formation of a splicing-dependent 40S complex (termed rna2A spliceosome) containing only the uncleaved premRNA (33) . In contrast, in the wild-type extract, the 40S spliceosome contains the uncleaved pre-mRNA as well as the processed splicing intermediates (4). With these extracts, the input RNAll protein did not sediment into the 40S region, but remained predominantly on top of the gradients ( Fig. 5C ; Table 1 ; see also below). Additionally, the results of the complementation experiments with either antisense or C259 mutant actin transcript also supported this argument ( Table 1 ; described below in detail).
To ascertain that the RNA11 protein does interact with the 40S spliceosome in a highly specific fashion, we treated the complementation mix with heparin, a polyanion used to eliminate nonspecific binding of proteins to RNAs (8, 17, 26) , before glycerol gradient centrifugation. This treatment resulted in the slower migration of both the 40S and 30S complexes on the gradient (Fig. 5B, top ; see also reference 17), presumably owing to the removal of nonspecific, or sometimes specific (e.g., binding of Ul snRNP to the spliceosome; discussed in reference 3), binding components from these two complexes. Despite the heparin treatment, the RNA11 protein still remained bound to the 40S spliceosome (Fig. 5B, bottom) . Centrifugation of the complementation mix in a high-salt (400 mM KCl) gradient gave a result similar to that of the heparin treatment, i.e., the interaction of the RNA11 protein with the now slower-migrating 40S complex still remained (Table 1) . Taken together, these data indicate that the interaction between the RNA11 protein and the 40S spliceosome is specific, not fortuitous.
To show that these results are not dependent on an unknown strain effect, we repeated the in vitro complementation experiment described above (Fig. 5A ) using an extract prepared from strain AJL145.9d and obtained the identical result (data not shown). Strain AJL145.9d is one of the mutant spores produced on sporulation of the diploid AJL145. This diploid was constructed by crossing the rnallcarrying strain, SPJ11.4, with the wild-type strain, B346B (36) anti-m3G and anti-Sm antibodies, respectively (Fig. 7, lanes resents the profile of 4 and 5). Conversely, when the nonfunctional complementext for details) obtation reaction was subjected to immunoprecipitation, only 2 ontrol RNAs from a to 3% of the input RNA11 protein was precipitated (Fig. 7, atE2, IVS*, El, As lanes 1 and 2). Since in such a nonfunctional complementance of ATP, RNA tion reaction essentially all the input 3 S-labeled RNA11 f the RNA11 protein protein remained free on top of the glycerol gradient (Table  'y RNA transcript, although of a lower specific activity, could also be detected as the coprecipitate (Fig. 7, lanes 4 and 5) .
In experiments with a transcript with a higher specific activity, coprecipitation of the RNA11 protein and the splicing intermediates (e.g., exon 1) was even more significant (data not shown). In summary, we showed that the RNA11 protein can be coprecipitated with the spliceosome or an snRNP by both anti-m G and anti-Sm antibodies. suggesting that the RNA11 protein is associated with splicing complexes during the in vitro complementation reaction.
Inhibition of mRNA splicing in vitro by anti-RNAI1 antibody. To learn more about the role of the RNA11 protein in niRNA splicing, we raised antibodies against the RNA11 protein. Oligonucleotide mutagenesis was used to introduce an EcoRI site upstream of the RNAII gene ( Fig. 1 and 2 ).
The RNAJI gene was then inserted into the E. coli expression vector pKK223-3 (5) for overexpression (Fig. 2) . In this construct, the RNAJII gene is under the control of the hybrid trp-lac (tac) promoter. E. coli cells containing this plasmid (pKK223-3-RNAII) or the parent plasmid were grown and induced with IPTG. Overproduction of the RNA11 protein was easily detected by total protein analysis on an SDSpolyacrylamide gel (Fig. 8A) . A strong 32-kDa band corresponding to the size of the RNA11 protein appeared only in the pKK223-3-RNAI/-containing cells subjected to IPTG induction (Fig. 8A, lane 4) . We estimated that the overproduced protein constitutes about 5% of the total proteins in cells induced with IPTG. The overproduced protein was purified by ammonium sulfate precipitation. heparin-agarose chromatography. and preparative SDS-PAGE and used to immunize rabbits.
The specific reactivity of the antibody that was raised was ascertained by the following criteria. On immunoblots of the yeast crude extract, the antibody recognized predominantly a 32-kDa protein, close to the estimated molecular size of the RNA11 protein (Fig. 8B, lane 2) . Preimmune serum failed to detect any protein in the same extract (lane 1). The antiserum was also able to detect a 32-kDa protein in the IPTGinduced E. coli strain carrying the plasmid pKK223-3-RNAII (lane 4). The 32-kDa protein was not visible in the same E. coli strain without IPTG induction (Fig. 8A, lane 3) , nor was it detected by the antiserum (Fig. 8B, lane 3) . Finally, the antibody was able to efficiently immunoprecipitate the in vitro-translated RNA11 protein (Fig. 8C, lane 8) as well as the truncated RNA11 protein (lane 6), but not the in vitro-translated globin protein (lane 4). Preimmune serum precipitated none of these in vitro-translated proteins (Fig.  8C, lanes 3, 5 and 7) . Thus, we conclude that the antibody is clearly specific for the RNA11 protein.
Antibody inhibition of mRNA splicing in vitro has been used to demonstrate the critical role of snRNPs (28, 43) and hnRNPs (9, 53) involved in mRNA splicing. We applied the same approach to verify the requirement of the RNAI I gene product for mRNA splicing.
Yeast splicing extract was preincubated with anti-RNA11, anti-m3G, or preimmune antibody at 0°C; then splicing was allowed to take place at 23°C (Fig. 9) . Addition of the preimmune antibody had no effect on splicing (lanes 1 to 3).
The anti-m3G antibody completely blocked all splicing reactions (lanes 7 and 8), even when as little as 0.5 ,ul was added. This result confirms the essential role of the capped snRNAs in mRNA splicing (7, 28) . The addition of 3 to 7 ,ul of the anti-RNAll antibody significantly inhibited splicing, although it did not block splicing completely (lanes 4 to 6). Quantitation of splicing by excision of RNA bands from the polyacrylamide gel and Cerenkov counting revealed that only 10 to 20% residual splicing remained (data not shown). Both steps of splicing were equally inhibited. Larger volumes of antibody could not be accommodated because the dilution inhibits splicing. Addition of smaller volumes of anti-RNA11 antibody caused less inhibition (data not shown). Presumably, the inability of the anti-RNA11 antibody to block splicing completely. in contrast to the results of the anti-m,G antibody, indicates a lower titer or affinity of the antibody. Preincubation of the splicing extract with the antibody was required to achieve inhibition. Addition of the antibody at the onset of the splicing reaction did not inhibit splicing to any significant extent (data not shown), a finding in line with the work of others (9, 43, 53) . Our results show that the binding of the RNA11-specific antibody to the RNA11 protein in splicing extracts prevents mRNA splicing, either by removing RNA11 protein or by altering its intrinsic activity. These results support the previous genetic observations (36) that the RNAII gene product is essential for mRNA splicing.
Location of RNAII protein in periphery of the yeast nucleus. Since, as we just showed, the RNA11 protein is associated with the spliceosome, we wanted to use the anti-RNA11 antibody in immunocytological analysis to determine the cellular location of the RNAll protein and thus the site of mRNA splicing. Because of the presumed low copy number of the RNAll protein, the accessibility of the protein in the cells had to be optimized for the immunofluorescence procedure. The cells used for immunofluorescence were first converted to spheroplasts, mounted on glass slides, and then fixed with 3.7% formaldehyde in buffer (10) .
The indirect immunofluorescence results with the wild- (Fig. 10C ) was done to show that this nuclear signal is due to the RNA11 antigen. In this experiment, 2 to 5 M equivalents of partially purified RNA11 protein were added to the anti-RNA11 antiserum dilution before the immunofluorescence staining. This treatment of the antiserum totally eliminated the nuclear signal (Fig. 10C) . Thus, these data strongly suggest that the RNA11 protein is localized in a region of the yeast nucleus. Closer examination of the nuclear location of the RNA11 protein revealed that the nuclear area stained by the anti-RNA11 antiserum, determined from 68 cells, consisted of 55% of the yeast nucleus as seen by Nomarski optics. This regional location for the RNA11 protein is most likely due to the exclusion of the RNA11 protein from the nucleolus. We tested this proposal by performing double-label immunofluorescence staining experiments using the rabbit anti-RNA11 antiserum and a human autoimmune antiserum to a nucleolar protein. This human autoimmune antiserum, referred to as fibrillarin (41), reacts with the yeast nucleolus (M. W. Clark and J. Abelson, unpublished data). The RNA11 protein appeared to be external to the nucleolus and occupied most of the nuclear area seen by Nomarski optics (Fig. 11C,  arrowheads) . Conversely, the fibrillarin antibody (Fig. llB) stained only a small portion of the nucleus with a thin crescent pattern. The yeast nucleolus, unlike the nucleolus of higher organisms, has been described as a crescent attached to the nuclear envelope (24, 53) . The localization for the RNA11 protein is not totally an unexpected result, since mRNA-splicing components are likely not to be required for rRNA processing.
An even more specific compartmentalization of the RNA11 protein and mRNA splicing was observed when the RNA11 protein localization was examined at a higher resolution by immunoelectron microscopy. Ultrathin sections of the Epon-embedded yeast cells were stained with the anti-RNA11 IgG or the preimmune IgG by the on-section staining technique (12) . The nuclear staining pattern caused by the anti-RNA11 IgG, as visualized with a goat anti-rabbit IgGcolloidal gold conjugate, is shown in Fig. 12 FIG. 9 . Inhibition of mRNA splicing by specific antibodies. After the wild-type extract was treated with preimmune serum (7, 5 , and 3 RI1; lanes 1 to 3), anti-RNA11 (7, 5 , and 3 p.; lanes 4 to 6), or anti-m3G antibody (2 and 1 pul; lanes 7 and 8), a standard mRNA splicing reaction was assembled for each treated extract to assess the degree of antibody inhibition. IVS*-E2, IVS*, E1-E2, and El, As described in the legend to Fig. 4B. as a point of reference and measuring the shortest distance from that point to the gold particles, both in and out of the nucleus. We then plotted these distances for anti-RNA11 IgG and preimmune IgG on the histograms shown in Fig.  12G and H, respectively. By comparing these two histograms, one can see definite staining for RNA11 in the nucleoplasm within about 300 nm from the nuclear envelope. This staining peaks around 75 to 100 nm from the nuclear envelope. The cytoplasmic staining with the anti-RNA11 antibody is probably due to the nonspecific background staining (cf. Fig. 12G and H; Table 2 ). We therefore conclude that the RNA11 protein is localized predominantly in the nucleoplasm at the periphery (within 300 nm) of the nuclear envelope.
DISCUSSION
In yeasts, most of the RNA gene products are likely to be involved in mRNA splicing in vitro (36) . Their roles, however, may vary. For instance, the RNA2 gene product is a factor extrinsic to the spliceosome required for completion of mRNA splicing, but not for the formation of the spliceosome itself (33) . It is likely that many of the RNA gene products are integral components of the spliceosome. Our goal was to search for such a spliceosome-specific marker, which may greatly facilitate research on the spliceosome in the future. In this report, we demonstrated, using an in vitro complementation assay, that the in vitro-synthesized RNAJ l gene product is active in complementing the genetic defect of the rnall extract. Moreover, we found that during the in vitro complementation reaction, the RNA11 protein is associated with both the 40S spliceosome and a 30S complex. RNAII gene product and in vitro complementation. Successive transcription and translation of the RNAJ I gene in vitro yielded a 32-kDa RNA11 protein (Fig. 3) . Under the conditions used, approximately 2.6 ng (87.5 fmol) of the RNAll protein was synthesized per jig of the input RNAJI transcript. Specific antibody raised against the RNA11 protein recognized predominantly a 32-kDa protein in the yeast extract and the E. coli RNA11-overproducer lysate (Fig.  8B) , indicating the fidelity of the in vitro translation.
The in vitro-synthesized RNA11 protein could complement the defect of the rnall extract (Fig. 4B) . The in vitro-translated globin and truncated RNA11 protein failed to do so (Fig. 4B) , demonstrating a specific requirement of the RNA11 protein for complementation. The failure of the truncated RNA11 protein to complement the lost splicing activity suggests that the C-terminal half is important for a fully functional RNA11 protein. It is interesting that the complementation assay worked only when heat inactivation (Fig. 7) . Recent immunoelectron microscopy studies with anti-RNA11 IgG to label the purified spliceosomes also suggest that RNA11 protein is present in the spliceosome (M. W. Clark et al., manuscript in preparation). One can calculate the stoichiometry between the RNA11 protein and the spliceosome by assuming that there is one exon 1 per spliceosome. The calculated result is 0.3 to 0.4 (RNA11 protein/exon 1), but the interpretation of this number is complicated by the finding that several spliceosome intermediates are involved in the mRNA splicing pathway (8, 27, 47) . Thus, the spliceosome as originally defined (4) is in fact a mixture of all these complexes, so there are likely to be 40S complexes which do not contain RNA splicing intermediates.
Nature of 30S complexes. During the in vitro complementation reaction, the RNA11 protein was also associated with a 30S particle (Fig. 5A and B (27) have recently reported that a 25S multi-snRNP particle containing U4/6 and U5 snRNPs is preformed in the HeLa nuclear extract and proposed that this multi-snRNP complex interacts with the U2-bound pre-mRNA to form the mature spliceosome. Interestingly, Cheng and Abelson (8) have also identified such a multi-snRNP in the yeast extract containing snRNAs (snR14, snR6, and snR7) homologous to the mammalian U4, U6, and U5, respectively. Unfortunately, the sedimentation coefficient of the yeast multi-snRNP is currently unknown. Most recently, Lossky et al. (35) have demonstrated, using anti-RNA8 antibodies, that the RNA8 protein is in stable association with snR7 and undergoes an additional ATP-dependent association with snR14 and snR6. These data are in good agreement with the observations described above, raising the possibility that the RNA11 protein is also an snRNP protein. Our preliminary studies with the RNA11-specific antibody failed to detect any snRNA specifically bound to the RNA11 protein. Perhaps RNAll protein is not easily accessible to the antibody, as suggested by our antibody inhibition experiments (Fig. 9) (32) . Our immunofluorescence-determined nuclear location for wild-type levels of the RNA11 protein agrees with this study. Our studies also demonstrated that at least one of the RNA gene products (i.e., the RNA11 protein) does not reside in the yeast nucleolus. About one-third of the yeast nuclear volume is directed toward rRNA synthesis and preribosome assembly (54) . The mRNA-splicing components appear not to have access to this area of the nucleus. This compartmentalization of function in the yeast nucleus seems to extend to even finer detail.
We showed that the RNA11 protein is located in the periphery of the nucleus, within a region 250 to 300 nm in from the nuclear envelope. The peak of the RNA11 protein location is about 75 to 100 nm in from the nuclear envelope. Other mRNA-splicing components show this same nuclear location. For instance, the anti-Sm (no. 58) antiserum was used in immunoelectron microscopy to localize the yeast Sm antigens, and its localization pattern appears to be similar to that of the RNA11 protein (M. W. Clark and J. Abelson, unpublished data). The compartmentalization of mRNAsplicing components that we observed in yeast cells has also been found in higher eucaryotes. Fakan and co-workers (14) have examined the distribution of hnRNPs and snRNPs by immunoelectron microscopy. By immunofluorescence microscopy, hnRNPs and snRNPs show both a distinct punctate and a diffuse nuclear staining pattern; in their study, Fakan and co-workers (14) present electron micrographs which reveal that the staining for both of these particles predominates in the periphery of the rat liver nucleus. These data, taken together, indicate that the mRNA-splicing components are not only sequestered into a macromolecular complex, the spliceosome, they are also located in a specific nuclear subcompartment, the nuclear periphery. One explanation for this subnuclear localization of mRNA splicing is that mRNA transcription is also occurring in the nuclear periphery. The mRNA-splicing components thus become localized by binding to the nascent precursor mRNAs.
Recent experiments to map the site of mRNA transcription place transcription components in the nuclear periphery. The yeast heat shock transcription factor, which binds to the promoter regions of the yeast heat shock genes (59) , has been mapped by immunofluorescence and immunoelectron microscopy to the same sites as the RNA11 and Sm proteins (M. W. Clark and J. Abelson, unpublished data). Also by immunoelectron microscopy, Clark and Hamkalo (11) have localized RNA polymerase II in the periphery of the mouse cell nucleus. This phenomenon of compartmen-talization of nuclear mRNA function seems to extend from yeasts to mammals and indicates its importance in proper nuclear function. The existence of a specific mechanism responsible for this nuclear organization may also be implied from these data. The tissue-specific ordering of the chromosomes reported in Drosophila larva nuclei (22, 23) , Purkinje cell nuclei (38) , and plant cell nuclei (21) might account for the observed compartmentalization of RNA-processing functions. In such a model of nuclear organization, the chromosomes would be arranged so that the sites of transcription are at the nuclear periphery where the RNAprocessing enzymes are concentrated. Experiments to investigate the placement of the chromosomes in the yeast interphase nucleus are currently under way (M. W. Clark and J. Abelson, unpublished data).
